Stock VAL VALIRX PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials ValiRx plc

Equities

VAL

GB00BLH13C52

Biotechnology & Medical Research

Delayed London S.E.
Other stock markets
 12:42:12 16/05/2024 pm IST 		5-day change 1st Jan Change
2.235 GBX +17.63% Intraday chart for ValiRx plc -27.90% -62.12%
15/05 Vertu Motors ups dividend as hails record revenue AN
15/05 AIM WINNERS & LOSERS: Itim up on Majestic Wine contract renewal AN

Valuation

Fiscal Period: December 2018 2020 2021 2022 2023
Capitalization 1 4.936 12.65 23.58 9.107 2.515
Enterprise Value (EV) 1 4.877 12.65 22.99 7.969 0.7146
P/E ratio -0.88 x -0.05 x - - -0.01 x
Yield - - - - -
Capitalization / Revenue - - - - -
EV / Revenue - - - - -
EV / EBITDA -1.31 x - - -4.33 x -0.35 x
EV / FCF -1.33 x - - - -0.34 x
FCF Yield -75.4% - - - -294%
Price to Book - - - - 0 x
Nbr of stocks (in thousands) 4,786 64,882 65,049 65,049 1,32,349
Reference price 2 1.031 0.1950 0.3625 0.1400 0.0190
Announcement Date 29/05/19 27/04/21 07/06/22 05/06/23 -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2020 2021 2022 2023
Net sales 1 - - - - -
EBITDA 1 -3.723 - - -1.842 -2.014
EBIT 1 -3.866 - -1.678 -2.593 -2.321
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -4.829 - - - -2.322
Net income 1 -4.299 -1.443 - - -2.132
Net margin - - - - -
EPS 2 -1.175 -3.810 - - -2.100
Free Cash Flow 1 -3.678 - - - -2.1
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 29/05/19 27/04/21 07/06/22 05/06/23 -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 0.06 - 0.59 1.14 1.8
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -3.68 - - - -2.1
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - - - - 4.400
Cash Flow per Share - - - - -
Capex 1 0.32 - - - 0.31
Capex / Sales - - - - -
Announcement Date 29/05/19 27/04/21 07/06/22 05/06/23 -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VALIRX PLC Stock ValiRx plc
-62.12% 31.86L
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+7.52% 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.38% 11TCr
BIONTECH SE Stock BioNTech SE
-12.64% 2.22TCr
ARGENX SE Stock argenx SE
+0.20% 2.23TCr
GENMAB A/S Stock Genmab A/S
-3.53% 1.94TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-37.85% 1.79TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-8.58% 1.72TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.41% 1.25TCr
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-23.95% 834.13Cr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VAL Stock
  4. Financials ValiRx plc
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW